CHICAGO — Patients with high-deductible health plans experienced delays in detection of metastatic cancer, according to results of an observational study presented during ASCO Annual Meeting.
“Specifically, we observed a delay in cancer diagnosis of 4.6 months,” Nicolas Karim Trad, BA, medical student at Harvard Medical School, said during his presentation.
Trad and colleagues examined the impact of high-deductible health plans on the timing of metastatic cancer detection among 345,401 individuals (mean age, 42 years; 49% female) with high-deductible health plans compared with